Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06375447

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

Study on an Intelligent Model for the Diagnosis and Treatment of Insomnia Disorder

Status
Recruiting
Phase
Study type
Observational
Enrollment
16,000 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Detailed description

The study endeavors to establish a multicenter cohort comprising 16,000 individuals diagnosed with insomnia disorder, with a subsequent 2-year follow-up. Objectives encompass elucidating the natural development of insomnia disorder within diverse populations, identifying associated factors, and evaluating the short-term and long-term impacts on physiological, psychological, and social functions in insomnia disorder. Additionally, the research aims to devise early screening methodologies, precise assessments, and innovative disease classifications utilizing real-time assessment technology within the insomnia disorder cohort. Furthermore, the investigation seeks to ascertain graded diagnoses, treatment modalities, and prognostic indicators based on advanced multi-dimensional real-time assessment technology applied to a substantial insomnia disorder cohort. Finally, the study aims to refine remote interactive diagnostic and treatment modalities tailored to diverse age groups, culminating in developing a systematic graded diagnostic and treatment framework for insomnia disorder.

Conditions

Interventions

TypeNameDescription
OTHERRoutine clinical treatmentRoutine clinical treatment is based on the latest international guidelines for insomnia.

Timeline

Start date
2022-12-01
Primary completion
2025-10-31
Completion
2025-12-31
First posted
2024-04-19
Last updated
2024-12-10

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06375447. Inclusion in this directory is not an endorsement.